Date:05/07/2006 URL: http://www.thehindu.com/2006/07/05/stories/2006070502921601.htm

Business - Briefly

FDA approval for Aurobindo Pharma drug

HYDERABAD: Aurobindo Pharma has received the first tentative new drug application (NDA) approval from the U.S. Food and Drug Administration for fixed dose combination drug product containing Lamivudine, Zidovudine and Nevirapine tablets used in the treatment of HIV-1 infection. The three drugs are now available in a single tablet, according to a company release.